SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-151327
Filing Date
2021-12-20
Accepted
2021-12-17 20:05:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 tm2131908-1_424b5.htm 424B5 932107
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 22587
3 GRAPHIC tm2131908d1-tbl_inter4clr.jpg GRAPHIC 90565
4 GRAPHIC tm2131908d1-tbl_exter14clr.jpg GRAPHIC 95719
5 GRAPHIC tm2131908d1-tbl_mate4clr.jpg GRAPHIC 146968
6 GRAPHIC tm2131908d1-tbl_early4clr.jpg GRAPHIC 102410
7 GRAPHIC tm2131908d1-tbl_inter14clr.jpg GRAPHIC 92482
8 GRAPHIC tm2131908d1-tbl_mate14clr.jpg GRAPHIC 120871
  Complete submission text file 0001104659-21-151327.txt   1859155
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-255089 | Film No.: 211503357
SIC: 2834 Pharmaceutical Preparations